The Technical Advisory Group on Alcohol and Drug Epidemiology (TAG-ADE) was established for technical advice to the WHO Secretariat on issues related to epidemiology of alcohol and drug use and related harm. Among the objectives of the TAG-ADE is further improvement of the quality of WHO estimates of alcohol and drug use in populations and alcohol- and drug-attributable disease burden and providing technical advice and recommendations on indicators, data collection procedures and estimates for prevention and treatment coverage for substance use disorders as well as on international research agenda for substance use and related health conditions.
The July 2025 meeting of TAG-ADE aims to launch the 2025–2027 term by confirming membership and leadership and reintroducing the group’s mandate and strategic direction. It will review new comparative risk assessment (CRA) methodologies for alcohol and drug use, with the goal of enhancing the accuracy and comparability of global burden estimates. The group will advise on the inclusion of additional conditions in global estimates, such as early-onset dementia and specific outcomes related to injection drug use. TAG-ADE will also provide technical feedback on WHO’s draft estimates of alcohol- and drug-attributable burden for upcoming reporting cycles and contribute to the development of normative products, including WHO reports and data tools relevant to alcohol and drug epidemiology.
For further information, please contact:
Anja Busse
Unit Head
Alcohol, Drugs and Addictive Behaviours
World Health Organization
e-mail: Anja Busse